The federal government is more likely to fund curiosity-driven basic research, while industry is more likely to support research that has a clearer eventual payoff.
Articles on Research funding
Displaying 1 - 20 of 308 articles
Taxpayer-funded investment supports basic research that can yield crucial medical advancements down the line and make lifesaving drugs and technologies affordable for everyday people.
To understand what makes space exploration worthwhile, we need to look beyond rigid cost–benefit analysis.
Chaos at the CDC and the sharp move away from mRNA vaccines has public health experts alarmed.
What happens if Trump cuts cancer research funding?
As the US cuts science funding and international cooperation, Australia and other countries see a chance to capitalise on this American brain drain.
Many of the world’s best and brightest STEM researchers have long moved to the US. But now that brain gain is at risk of reversing to become a brain drain, with science funding and visas in chaos.
The tools that feminist science studies have developed are critical to the sciences because they ask new questions, and develop new methodologies.
A scholar reveals the ins and outs of how research gets funded, including the checks and balances that ensure high scientific standards and financial integrity at every stage of a grant’s lifecycle.
Science can help boost national economic productivity in many ways. But it needs to be properly supported.
The Trump administration has terminated hundreds of federal grants that support engineering, biology, geology, computer science, STEM education and much more.
There are several steps between research on seemingly esoteric subjects and breakthrough medical treatments. Ethical oversight at every stage ensures science and society ultimately benefit.
Basic research that doesn’t have a specific industrial or experimental application still adds value outside the lab by engaging people with exciting research.
Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death rates. This may soon no longer be the case.
The National Institutes of Health has been integral to scientific progress in treating countless human diseases. Without its support, patients will ultimately pay the price.
Trump’s DEI-related executive orders may affect early career scientists and researchers who study representation in science, but most research grants are unaffected.
The jury’s out on whether the US is still at the top of global science. Proposed cuts to major agencies could mean completely ceding that title.
The consequences of a U.S. retreat from the global response to HIV/AIDS would be immense, jeopardizing 40 years of progress.
It costs money to maintain the various facilities, utilities and personnel that allow scientists to conduct research in the first place. Without federal support, institutions are left scrambling.
A member of a grant review panel explains the ins and outs of applying for research funding – and the consequences of when the process suddenly stops.
Top contributors
-
Director, UNSW Sydney
-
Chief Executive, CSIRO
-
Director, Engagement at the Australian Academy of Science and Associate Professor (hon) at the Centre for Public Awareness of Science, Australian National University
-
Professor of Natural Philosophy in the Department of Physics, University of York
-
Professor of Statistics, Queensland University of Technology
-
Executive Director, Development & Communications, Australian Technology Network of Universities
-
Secretary for Science Policy at the Australian Academy of Science, and Senior Deputy Vice-Chancellor, UNSW Sydney
-
Adjunct professor, University of Canberra
-
Adjunct Professor, University of Sydney
-
Emeritus Professor, Australian National University
-
Professor of Health Economics, Duke-NUS Medical School
-
Associate Professor, Researcher Development (EMCR), La Trobe University
-
Associate professor of economy and society, Macquarie University
-
Previous Vice President of the Academy of Science of South Africa and DSI-NRF SARChI chair in Fungal Genomics, Professor in Genetics, University of Pretoria, University of Pretoria
-
ARC Laureate Fellow, Swinburne University of Technology